1. Chen, Wen-Hui, Cai, Mu-Yan, Zhang, Jia-Xing, Qian, Chao-Nan, Xie, Dan. 2018. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. In Oncogene, 37, 6243-6258. doi:10.1038/s41388-018-0351-8. https://pubmed.ncbi.nlm.nih.gov/30013189/
2. Welton, Thomas, Chew, Gabriel, Mai, Aaron Shengting, Chan, Ling Ling, Tan, Eng-King. 2024. Association of Gene Expression and Tremor Network Structure. In Movement disorders : official journal of the Movement Disorder Society, 39, 1119-1130. doi:10.1002/mds.29831. https://pubmed.ncbi.nlm.nih.gov/38769620/
3. Lu, Guomin, Wang, Hui, Xu, Rui, Zhan, Qiang, Zhang, Qinglin. 2023. Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response. In Journal of Cancer, 14, 2978-2989. doi:10.7150/jca.86965. https://pubmed.ncbi.nlm.nih.gov/37859818/
4. Wang, Xiaoxiao, Wang, Zilong, Liu, Baiyi, Rao, Huiying, Liu, Feng. 2023. Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH. In Frontiers in immunology, 14, 1098056. doi:10.3389/fimmu.2023.1098056. https://pubmed.ncbi.nlm.nih.gov/36911682/
5. Yang, Xing-Yi, Liao, Jun-Jie, Xue, Wu-Rong. 2019. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC). In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 117, 109126. doi:10.1016/j.biopha.2019.109126. https://pubmed.ncbi.nlm.nih.gov/31387165/